<DOC>
	<DOCNO>NCT00628108</DOCNO>
	<brief_summary>To determine safety levocetirizine child age 6-11 month symptom allergic rhinitis chronic idiopathic urticaria .</brief_summary>
	<brief_title>Safety Study Levocetirizine Dihydrochloride Oral Liquid Formulation Children Aged 6 Months 11 Months</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>Outpatient , male female pediatric subject , age 6 11 month ( 6 month &lt; 1 year ) randomization visit The subject must present least one symptom commonly associate allergic rhinitis chronic idiopathic urticaria Candidate antihistamine treatment receive antihistamine past similar symptom present Any clinically significant medical condition abnormality primary diagnosis antihistamine indicate Be initiate change dose immunotherapy regimen course study ( Visit 1 Visit 4 ) Any Electrocardiogram ( ECG ) parameter , include QTcF interval &gt; 443 msec measure ECG obtain Screening Visit , outside normal reference range Any clinical laboratory test perform Screening Visit , related allergic condition , outside reference range . Subjects value outside accept reference range include Investigator 's opinion , clinical significance Personal history seizure , febrile seizure sleep apnea Below lower 5th 95th percentile body weight and/or height base upon CDC Growth Charts Body Weight Length Allergy intolerance levocetirizine dihydrochloride excipients , piperazine derivative , hydroxyzine , cetirizine , cyclizine , meclozine , buclizine Current past intake ( include exposure breast milk ) follow medication within specify washout period Randomization Visit ( V2 ) : Systemic corticosteroid within past 28 day Leukotrienereceptor antagonist ( e.g . montelukast [ Singulair ] zafirlukast [ Accolate ] within past 7 day ) Mastcell stabilizer ( e.g . cromolyn nedocromil ) within past 7 day Other antihistamine cough cold preparation ( exception single ingredient guaifenesin product ) , overthecounter ( OTC ) sleep aid medication within past 7 day Systemic antibiotic within past 7 day Other concomitant medication interfere study , opinion investigator Previous participation another clinical/pharmacological trial within past month prior V1 Have already participate study participate study another site Children member study site staff Sibling sleep apnea sudden infant death syndrome ( SIDS ) Exposure condition know potential risk factor SIDS , limit ( determined case case basis take account subject 's entire medical history environmental living condition ) : Mothers smoke abused drug pregnancy Extremely young mother ( define age 19 young pregnant ) Children currently expose caregiver heavy cigarette smoker ( define smoking least pack cigarette per day ) Babies sleep regularly face put sleep back Premature birth gestational age â‰¤ 37 week ) low birth weight ( 10 percentile gestational age )</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>11 Months</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Xyzal</keyword>
	<keyword>Levocetirizine</keyword>
	<keyword>Allergy</keyword>
	<keyword>Children</keyword>
	<keyword>Seasonal Allergies</keyword>
</DOC>